. . . "55"^^ . . . . "Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia"@nl . . . . . . . . "Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)"@en . "Phase I/II Study Combining Humanised Anti-CD20 (Veltuzumab), Anti-CD22 (Epratuzumab) and Both Monoclonal Antibodies With Intensive Chemotherapy in Adults With Recurrent or Refractory B-precursor Acute Lymphoblastic Leukaemia (ALL)"@en . . . . "MARALL"@en . . . "klinisch onderzoek"@nl . "2010-01-01T00:00:00Z"^^ . "Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia"@nl . "NCT01279707" . . "clinical trial"@en . "2014-08-01T00:00:00Z"^^ . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . "Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)"@en . . . . . "ensayu cl\u00EDnicu"@ast . . "Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)"@en . "Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia"@nl . . . "16"^^ . . . . . . . . . . . . . . . .